G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer Patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer Patients
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-21
DOI
10.3389/fendo.2021.564002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
- (2020) Youn-Sang Jung et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epigenetic therapy for ovarian cancer: promise and progress
- (2019) Sara Moufarrij et al. Clinical Epigenetics
- Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients
- (2019) Eileen Deuster et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancer
- (2019) Bastian Czogalla et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The developmental Wnt signaling pathway effector β-catenin/TCF mediates hepatic functions of the sex hormone estradiol in regulating lipid metabolism
- (2019) Lili Tian et al. PLOS BIOLOGY
- WNT Signaling in Tumors: The Way to Evade Drugs and Immunity
- (2019) Elena Martin-Orozco et al. Frontiers in Immunology
- Dkk2 promotes neural crest specification by activating Wnt/β-catenin signaling in a GSK3β independent manner
- (2018) Arun Devotta et al. eLife
- The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients
- (2017) Helene Heidegger et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeted therapy of ovarian cancer including immune check point inhibitor
- (2017) Jin Young Kim et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications
- (2016) Ivo Meinhold-Heerlein et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Not lost in translation: Emerging clinical importance of the G protein-coupled estrogen receptor GPER
- (2016) Matthias Barton STEROIDS
- Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer
- (2014) Martin Sjöström et al. BREAST CANCER RESEARCH AND TREATMENT
- Distinct roles of DKK1 and DKK2 in tumor angiogenesis
- (2013) Hongryeol Park et al. ANGIOGENESIS
- Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells
- (2013) H Hirata et al. BRITISH JOURNAL OF CANCER
- The G-Protein Coupled Estrogen Receptor (GPER/GPR30) is a Gonadotropin Receptor Dependent Positive Prognosticator in Ovarian Carcinoma Patients
- (2013) Sabine Heublein et al. PLoS One
- The G-protein-coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian cancer cells by blocking tubulin polymerization
- (2013) C Wang et al. Cell Death & Disease
- GPER-1 acts as a tumor suppressor in ovarian cancer
- (2013) Tanja Ignatov et al. Journal of Ovarian Research
- Estrogen regulation of Dkk1 and Wnt/β-Catenin signaling in neurodegenerative disease
- (2012) Erin L. Scott et al. BRAIN RESEARCH
- Epigenetic Resensitization to Platinum in Ovarian Cancer
- (2012) D. Matei et al. CANCER RESEARCH
- Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma
- (2012) Jing Zhu et al. CARCINOGENESIS
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- Minireview: G Protein-Coupled Estrogen Receptor-1, GPER-1: Its Mechanism of Action and Role in Female Reproductive Cancer, Renal and Vascular Physiology
- (2012) Edward J. Filardo et al. ENDOCRINOLOGY
- A Phytoestrogen Diarylheptanoid Mediates Estrogen Receptor/Akt/Glycogen Synthase Kinase 3β Protein-dependent Activation of the Wnt/β-Catenin Signaling Pathway
- (2012) Kanit Bhukhai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ten-Year Relative Survival for Epithelial Ovarian Cancer
- (2012) Lauren A. Baldwin et al. OBSTETRICS AND GYNECOLOGY
- The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer
- (2012) Zuzana Kolkova et al. Journal of Ovarian Research
- GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer
- (2012) Satoe Fujiwara et al. Journal of Ovarian Research
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- The G-protein-coupled estrogen receptor GPER in health and disease
- (2011) Eric R. Prossnitz et al. Nature Reviews Endocrinology
- Epigenetic disruption of the WNT/ß-catenin signaling pathway in human cancers
- (2010) Ying Ying et al. Epigenetics
- Wnt signal transduction pathways
- (2010) Yuko Komiya et al. Organogenesis
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
- (2009) Andreas du Bois et al. CANCER
- Retracted: G-Protein–Coupled Receptor 30 and Estrogen Receptor-α Are Involved in the Proliferative Effects Induced by Atrazine in Ovarian Cancer Cells
- (2008) Lidia Albanito et al. ENVIRONMENTAL HEALTH PERSPECTIVES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started